Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Israel
100%
Healthcare Workers
100%
Neutralizing Antibodies
100%
SARS-CoV-2 Omicron
100%
Immunoglobin G
100%
Symptomatic Disease
100%
Omicron Variant Infection
100%
Fold Increase
66%
Odds Ratio
66%
Infection Rate
50%
Infectivity
50%
Omicron Infection
50%
Antibody Level
33%
Risk Reduction
33%
Post-infection
33%
MRNA Vaccine
33%
Omicron Variant
33%
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
33%
COVID-19
16%
Prospective Cohort Study
16%
Infection Risk
16%
PCR Test
16%
Ligand-binding Domain
16%
Online Survey
16%
G-levels
16%
Cycle Threshold
16%
Humoral Response
16%
Age 50
16%
Chain Reaction
16%
Disease Analysis
16%
Reaction Test
16%
Exposure Event
16%
Breakthrough Infection
16%
SARS-CoV-2 Variants
16%
Infection Analysis
16%
Antireceptor
16%
Infectivity Analysis
16%
MRNA COVID-19 Vaccine
16%
Antigen Detection
16%
Serological Tests
16%
Protection against Infection
16%
Female Health Workers
16%
Antibody Titer Level
16%
Immunology and Microbiology
Infectious Disease
100%
Severe Acute Respiratory Syndrome Coronavirus 2
100%
Omicron Coronavirus Variant
100%
Infection
100%
Intravenous Immunoglobulin
46%
Neutralizing Antibody
46%
Antibody Titer
30%
Severe Acute Respiratory Syndrome
15%
Wild Type
7%
Humoral Immunity
7%
Serology
7%
COVID-19
7%
Antigen
7%
Breakthrough Infection
7%
Cycle Threshold
7%
Pharmacology, Toxicology and Pharmaceutical Science
SARS Coronavirus
100%
Infection
100%
Diseases
100%
Immunoglobulin
42%
Neutralizing Antibody
42%
Severe Acute Respiratory Syndrome
14%
mRNA Vaccine
14%
Cohort Study
7%
Prospective Cohort Study
7%
Antigen
7%
COVID-19 Vaccine
7%
Messenger RNA
7%